ID

24735

Description

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00583830

Link

https://clinicaltrials.gov/show/NCT00583830

Keywords

Versions (1)
  1. 8/15/17 8/15/17 -
Uploaded on

August 15, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non Small Cell Lung Cancer NCT00583830

English

Eligibility Non Small Cell Lung Cancer NCT00583830

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with histologically or cytologically confirmed stage iiib or stage iv advanced primary non-small cell lung cancinoma
Description

Non-Small Cell Lung Carcinoma Primary Advanced TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205225
UMLS CUI [1,3]
C0205179
UMLS CUI [1,4]
C3258246
age 18 years or older
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
received investigational (not yet approved by a regulatory authority) or non-investigational agent to treat lung cancer
Description

Investigational New Drugs Carcinoma of lung | Pharmaceutical Preparations Carcinoma of lung

Data type

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0684249
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0684249
received radiation therapy within 4 weeks before randomization
Description

Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C1522449
major surgery within 4 weeks before randomization
Description

Major surgery

Data type

boolean

Alias
UMLS CUI [1]
C0679637
minor surgery within 2 weeks before randomizaiton
Description

Minor Surgical Procedures

Data type

boolean

Alias
UMLS CUI [1]
C0038904
systemic steroids within 1 week before randomization
Description

systemic steroids

Data type

boolean

Alias
UMLS CUI [1]
C2825233
any grade 2 or greater neuropathy
Description

Neuropathy CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C1516728
history of severe (grade 4) hypersensitivity reaction to products containing cremophor el (cyclosporine, teniposide)
Description

Hypersensitivity Product Containing Cremophor EL | Hypersensitivity Severe CTCAE Grades | Hypersensitivity Cyclosporine | Hypersensitivity Teniposide

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1514468
UMLS CUI [1,3]
C0332256
UMLS CUI [1,4]
C0056476
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C1516728
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0010592
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0039512
history of any infection requiring hospitalization or antibiotics within 2 weeks before randomization
Description

Communicable Disease Hospitalization Required | Communicable Disease Requirement Antibiotics

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C1708385
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0003232
known brain or spinal cord metastases
Description

Metastatic malignant neoplasm to brain | Secondary malignant neoplasm of spinal cord

Data type

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0347016
history of other cancers within 5 years before randomization
Description

Malignant Neoplasms

Data type

boolean

Alias
UMLS CUI [1]
C0006826
known hiv, hepatitis-b or hepatitis-c infection
Description

HIV Infection | Hepatitis B | Hepatitis C

Data type

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
pregnant or breast-feeding women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
previously treated with mapatumumab
Description

mapatumumab

Data type

boolean

Alias
UMLS CUI [1]
C1665688
Back to the top of the page

Similar models

Eligibility Non Small Cell Lung Cancer NCT00583830

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Primary Advanced TNM clinical staging
Item
patients with histologically or cytologically confirmed stage iiib or stage iv advanced primary non-small cell lung cancinoma
boolean
C0007131 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,3])
C3258246 (UMLS CUI [1,4])
Age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Investigational New Drugs Carcinoma of lung | Pharmaceutical Preparations Carcinoma of lung
Item
received investigational (not yet approved by a regulatory authority) or non-investigational agent to treat lung cancer
boolean
C0013230 (UMLS CUI [1,1])
C0684249 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C0684249 (UMLS CUI [2,2])
Therapeutic radiology procedure
Item
received radiation therapy within 4 weeks before randomization
boolean
C1522449 (UMLS CUI [1])
Major surgery
Item
major surgery within 4 weeks before randomization
boolean
C0679637 (UMLS CUI [1])
Minor Surgical Procedures
Item
minor surgery within 2 weeks before randomizaiton
boolean
C0038904 (UMLS CUI [1])
systemic steroids
Item
systemic steroids within 1 week before randomization
boolean
C2825233 (UMLS CUI [1])
Neuropathy CTCAE Grades
Item
any grade 2 or greater neuropathy
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Hypersensitivity Product Containing Cremophor EL | Hypersensitivity Severe CTCAE Grades | Hypersensitivity Cyclosporine | Hypersensitivity Teniposide
Item
history of severe (grade 4) hypersensitivity reaction to products containing cremophor el (cyclosporine, teniposide)
boolean
C0020517 (UMLS CUI [1,1])
C1514468 (UMLS CUI [1,2])
C0332256 (UMLS CUI [1,3])
C0056476 (UMLS CUI [1,4])
C0020517 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C1516728 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C0010592 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0039512 (UMLS CUI [4,2])
Communicable Disease Hospitalization Required | Communicable Disease Requirement Antibiotics
Item
history of any infection requiring hospitalization or antibiotics within 2 weeks before randomization
boolean
C0009450 (UMLS CUI [1,1])
C1708385 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0003232 (UMLS CUI [2,3])
Metastatic malignant neoplasm to brain | Secondary malignant neoplasm of spinal cord
Item
known brain or spinal cord metastases
boolean
C0220650 (UMLS CUI [1])
C0347016 (UMLS CUI [2])
Malignant Neoplasms
Item
history of other cancers within 5 years before randomization
boolean
C0006826 (UMLS CUI [1])
HIV Infection | Hepatitis B | Hepatitis C
Item
known hiv, hepatitis-b or hepatitis-c infection
boolean
C0019693 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
pregnant or breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
mapatumumab
Item
previously treated with mapatumumab
boolean
C1665688 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial